GlassScriptPhysician profile
Darron M Jones
NPI 1285629519
$5,859.42
in general payments reported to CMS, 2019-2025
12 companies · $114 in 2025
The $114 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $397 · 2020: $967 · 2021: $190 · 2022: $429 · 2023: $344 · 2024: $3,419 · 2025: $114.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,979 · Food and Beverage: $1,613 · Education: $285.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,979.48 |
| Food and Beverage | $1,613.20 |
| Education | $284.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $3,540.83 | 2022-2025 | Persona, Mymobility Platform, Rosa |
| Smith+Nephew, INC. | $1,460.25 | 2019-2025 | Real Intelligence, R3 Acetabular, Acufex Trunav |
| Depuy Synthes Sales INC. | $439.07 | 2019-2025 | Na, Dynaforce |
| Stryker Corporation | $194.56 | 2019-2023 | Triathlon |
| Ethicon US, LLC | $52.56 | 2019 | |
| Heron Therapeutics, INC. | $35.63 | 2022-2023 | Zynrelef |
| Integra Lifesciences Corporation | $33.86 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Kerecis Limited | $22.95 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Heraeus Medical, LLC. | $22.80 | 2021-2022 | |
| Bioventus LLC | $20.75 | 2019 | |
| Organogenesis INC. | $19.35 | 2019 | |
| Convatec INC. | $16.81 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Darron Jones listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.